Obama Administration Says 'No' To Global Health Fund For Developing Nations
WASHINGTON -- The Obama administration has alarmed global health experts by opposing a new international fund that would fight disease in the developi...
WASHINGTON -- The Obama administration has alarmed global health experts by opposing a new international fund that would fight disease in the developi...
The Center for Public Integrity | Posted 04.04.2012
By Kimberly Leonard, iWatch NewsA federal judge's decision to block imports of a drug used in executions will leave states to rely more on a substit...
Martha Rosenberg | Posted 04.18.2012
It was not a great surprise that the FDA's new cephalosporin livestock rules have the Agribusiness Seal of Approval. It was Big Pharma and Agribusiness lobbying that killed its stronger cephalosporin rules issued four years after.
HuffingtonPost.com | Zach Carter | Posted 12.16.2011
Ryan Grim contributed reporting WASHINGTON -- A month ago, Google lobbyist Katherine Oyama absorbed one of the more unusual congressional tongue-la...
Martha Rosenberg | Posted 02.13.2012
It used to be joked that a consultant is someone who borrows your watch to tell you what time it is. These days, the opportunist is Big Pharma, which raises your insurance premiums and taxes while providing you "low-priced" drugs that you paid for.
Jonathan D. Moreno | Posted 02.05.2012
So far in this election cycle, the only vaguely relevant recognition of the importance of leadership in biotechnology for the country's future was a polemical and uninformative exchange on vaccination policy.
HuffingtonPost.com | Zach Carter | Posted 11.17.2011
WASHINGTON -- At a House Judiciary Committee hearing Wednesday, Democrats and Republicans joined together to voice support for legislation that would ...
HuffingtonPost.com | Zach Carter | Posted 12.05.2011
This piece is a continuation of The Huffington Post's collaboration on trade issues with The Dylan Ratigan Show, called Trading Our Future. WASHING...
Mark Steinberg | Posted 11.14.2011
A quick read of President Obama's 4,000 word jobs speech to Congress on September 8 reveals that he has apparently decided there are no folks in Ame...
HuffingtonPost.com | Zach Carter | Posted 10.04.2011
WASHINGTON -- After months of dead-end negotiations over raising the federal debt ceiling, President Barack Obama walked into the East Room of the Whi...
HuffingtonPost.com | Ryan Grim | Posted 09.07.2011
WASHINGTON -- Democrats have targeted pharmaceutical profits as a means of raising revenue as part of the debt ceiling deal, Rep. Chris Van Hollen (D-...
Roll Call | John Stanton | Posted 08.29.2011
How does a policy earmark worth more than $214 million garner the votes of conservatives such as GOP Reps. Michele Bachmann (Minn.) and Ron Paul (Texa...
Craig Newmark | Posted 05.25.2011
Hey, the folks at ProPublica do true public service media, funded philanthropically and according to a strict code of ethics. The code is a really big...
James Love | Posted 05.25.2011
A number of NGOs working on public health issues are concerned that the President may push India to adopt more strict intellectual property protections on pharmaceutical drugs. They have reasons to be concerned.
Dr. Jeffrey H. Toney | Posted 05.25.2011
The pharmaceutical industry relies predominately upon patent protection of intellectual property to yield profits that are critical to support research and development, but there are exceptions that demonstrate the value of open innovation.
ProPublica | Jeff Gerth | Posted 05.25.2011
GE Healthcare ignored the advice of its own safety experts to "proactively" restrict use of its imaging drug, Omniscan, after reports in Europe linked...
AP | ALAN FRAM | Posted 05.25.2011
WASHINGTON — Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President ...
Francine Hardaway | Posted 11.17.2011
In this deal, Medicare Part D (prescription drug benefit) was passed with a right of the pharmaceutical companies to raise drug prices during the open enrollment period.
AP | ERICA WERNER | Posted 05.25.2011
WASHINGTON — The head of the influential trade association for drug manufacturers announced Thursday night that he is leaving his job. The deve...
Bloomberg | David Evans | Posted 05.25.2011
Pfizer and Lilly lead a parade of U.S. companies that have paid $7 billion in penalties after promoting drugs for uses not approved by the FDA. This u...
HuffingtonPost.com | Ryan Grim | Posted 05.25.2011
Sen. Bill Nelson, a Florida Democrat, said on Sunday that if leadership doesn't work with him on his amendment that would break the White House deal w...
Wall Street Journal | JANET ADAMY and GREG HITT | Posted 05.25.2011
The drug industry stands to gain in a health-care overhaul by getting tens of millions of newly insured customers, while insurance companies -- especi...
New York Times | DAVID D. KIRKPATRICK | Posted 05.25.2011
Facing last-minute liberal resistance in Congress, the drug industry is bracing for an increase in its share of the cost of the proposed health care o...
Wall Street Journal | GREG HITT | Posted 05.25.2011
Republicans are preparing an alternative health-care bill to Democratic legislation, House Republican Leader John Boehner said, marking a shift in str...
AP | MATTHEW PERRONE | Posted 05.25.2011
WASHINGTON — As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical ...
HuffingtonPost.com | Zach Carter | Posted 05.25.2012